Woodward, Michael

A/Prof Michael Woodward AM

Geriatrician; Director, Dementia Research, Austin Health
A/Prof Michael Woodward AM is a Senior Geriatrician with a passion for health promotion in older people, including vaccine-preventable diseases. He is Director of Aged Care Research at Austin Health and has conducted several trials of vaccines. He is a member of the Scientific Advisory Committee of the Immunization Coalition and has written the Position Paper on Immunization of older people for the Australian and New Zealand Society of Geriatric Medicine. In 2016 he received Membership of the Order of Australia for his work in geriatric medicine and his communication to professionals.

More from this expert

This article discusses how GPs can improve the vaccination coverage among older Australians which is currently poor despite the ready availability, safety and effectiveness of these vaccines. Written by A/Prof Michael Woodward AM, MB, BS, MD, FRACP, and A/Prof John Litt MB, BS, DRACOG, MSc(Epid), FRACP, FAFPHM, PhD

Monographs iconMonographs

Latest evidence-based recommendations on how people can preserve their cognitive function as they age, and slow the progression to dementia.

Podcasts iconPodcasts

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

Videos iconVideos

The importance of accurately diagnosing mild cognitive impairment early

Podcasts iconPodcasts

We have two VZ vaccines both quite different in terms of efficacy, duration of protection, costs, contraindications, and dosing schedules

Podcasts iconPodcasts

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.

Videos iconVideos

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Podcasts iconPodcasts

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

Videos iconVideos

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Podcasts iconPodcasts

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Podcasts iconPodcasts

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

Videos iconVideos

A timely expert discussion on how new dementia diagnostics and therapies are reshaping primary care.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.